Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823764) titled 'Study of CM583 in Healthy Participants' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Keymed Biosciences Co.Ltd

Condition: Healthy

Intervention: Biological: CM583

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 2026

Target Sample Size: 40

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07823764

Published by HT Digital Content S...